The 3rd Annual IASLC-endorsed Texas Lung Cancer Conference is taking place at the iconic ACL Live at the Moody Theater in Austin, Texas! This 2-day CE conference will delve into the latest breakthroughs and debates in lung cancer care, equipping oncologists and cancer care providers with the cutting-edge knowledge needed to deliver top-tier care. The management of lung cancer is becoming increasingly intricate, driven by the remarkable advancements in immunotherapy, targeted therapy, and innovative treatments. Learn how to effectively utilize these therapies directly from the researchers pioneering these advancements. Sessions will range from foundational topics (“What is NGS?”) to more complex discussions (“How do we choose the optimal first-line therapy for EGFR mutant NSCLC?”), making this conference valuable for professionals at all stages of their careers.
The 2025 Texas Lung Cancer Conference is more than just a review of existing data—it’s an opportunity to grasp the rationale behind key trials and the optimal strategies for patient care. In addition to short, focused topic reviews, the meeting features interactive panel discussions, live Q&A, and plenty of networking opportunities.